IL13 and psoriasis: Our findings showed an association between type I psoriasis and 10 SNPs (N = 155 versus N = 197 controls): rs1634517 (CCL4L), rs1975974 (C17orf51), rs12720356 (TYK2), rs1800925 (IL13), and rs6908425 (CDKAL1) decreased the risk of psoriasis 2.94-fold, 2.08-fold, 10-fold, 100-fold, and 2.44-fold, respectively; and rs2282276 (CLMN), rs10782001 (FBXL19), rs3792876 (SLC22A4), rs12191877 (HLA-C), and rs13437088 (HLA-B/MICA) increased the risk of psoriasis 3.90-fold, 2.10-fold, 3.75-fold, 30.54-fold, and 2.52-fold, respectively (Table 2).